Green tea as an agricultural based health promoting food: The past five to ten years

Agriculture (Switzerland)

Volumn 2, Issue 4, 2012, Pages 393-413

  Shi, Qin Yin ^a   Schlegel, Vicki ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Catechins; Flavonoids; Green tea; Health; Inflammation; Oxidative stress; Phenols

Indexed keywords

EID: 84880410159     PISSN: None     EISSN: 20770472     Source Type: Journal    
DOI: 10.3390/agriculture2040393     Document Type: Article

References (88)

1. Khokhar, S.; Magnusdottir, S.G.M. Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J. Agric. Food Chem. 2002, 50, 565–570.
2. Moxham, R. Tea: Addiction, Exploitation, and Empire; Carroll & Graf Publishers: New York, NY, USA, 2003.
3. Pettigrew, J. The Tea Companion: A Connoisseur’s Guide, 1st ed.; Running Press Book Publishers: Philadelphia, PA, USA, 2004.
4. Li, X. Study on the Competitiveness of Chinese Tea in the Global Market. Master’s Thesis, Nanjing Agricultural University, Nanjing, China, 2004.
5. FAO Web site. Available online: Http://faostat3.fao.org/home/index.html (accessed on 18 September 2012).
6. Singh, B.N.; Shankar, S.; Srivastava, R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 2011, 82, 1807–1821.
7. Butt, M.S.; Sultan, M.T. Green tea: Nature’s defense against malignancies. Crit. Rev. Food Sci. Nutr. 2009, 49, 463–473.
8. Cabrera, C.; Artacho, R.; Giménez, R. Beneficial effects of green tea—A review. J. Am. Coll. Nutr. 2006, 25, 79–99.
9. Balentine, D.A.; Wiseman, S.A.; Bouwens, L.C.M. The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr. 1997, 37, 693–704.
10. Lin, L.Z.; Chen, P.; Harnly, J.M. New phenolic components and chromatographic profiles of green and fermented teas. J. Agric. Food Chem. 2008, 56, 8130–8140.
11. Hatanaka, A. The biogeneration of green odour by green leaves. Phytochemistry 1993, 34, 1201–1218.
12. Wang, Y.; Wei, X.; Jin, Z. Structure analysis of a neutral polysaccharide isolated from green tea. Food Res. Int. 2009, 42, 739–745.
13. Chen, H.; Zhang, M.; Qu, Z.; Xie, B. Antioxidant activities of different fractions of polysaccharide conjugates from green tea (Camellia sinensis). Food Chem. 2007, 106, 559–563.
14. Circu, M.L.; Aw, T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 2010, 48, 749–762.
15. Kowaltowski, A.J.; Souza-Pinto, N.C.; Castilho, R.F.; Vercesi, A.E. Mitochondria and reactive oxygen species. Free Radic. Biol. Med. 2009, 47, 333–343.
16. Schroeder, E.K.; Kelsey, N.A.; Doyle, J.; Breed, E.; Bouchard, R.J.; Loucks, F.A.; Linseman, D.A. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid. Redox Signal. 2009, 11, 469–480.
17. Guo, S.; Yan, J.; Yang, T.; Yang, X.; Bezard, E.; Zhao, B. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson’s Disease through inhibition of ROS-NO pathway. Biol. Psychiatry 2007, 62, 1353–1362.
18. Quesada, I.M.; Bustos, M.; Blay, M.; Pujadas, J.; Ardèvol, A.; Salvadó, M.J.; Bladé, C.; Arola, L.; Fernández-Larrea, J. Dietary catechins and procyanidins modulate zinc homeostasis in human HepG2 cells. J. Nutr. Biochem. 2011, 22, 153–163.
19. Wei, H.; Meng, Z. Protective effects of epigallocatechin-3-gallate against lead-induced oxidative damage. Hum. Exp. Toxicol. 2010, 30, 1521–1528.
20. Lambert, J.D.; Elias, R.J. The antioxidant and pro-oxidant activities of green tea polyphenols: A role in cancer prevention. Arch. Biochem. Biophys. 2010, 501, 65–72.
21. Maeta, K.; Nomura, W.; Takatsume, Y.; Izawa, S.; Inoue, Y. Green tea polyphenols function as prooxidants to activate oxidative-stress-responsive transcription factors in yeasts. Appl. Environ. Microbiol. 2007, 73, 572–580.
22. Elbling, L.; Herbacek, I.; Weiss, R.-M.; Jantschitsch, C.; Micksche, M.; Gerner, C.; Pangratz, H.; Berger, W. Hydrogen peroxide mediates EGCG-induced antioxidant protection in human keratinocytes. Free Radic. Biol. Med. 2010, 49, 1444–1452.
23. Lin, W.; Karin, M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Investig. 2007, 117, 1175–1183.
24. Lumeng, C.N.; Saltiel, A.R. Inflammatory links between obesity and metabolic disease. J. Clin. Investig. 2011, 121, 2111–2117.
25. Smith, G.R.; Missailidis, S. Cancer, inflammation and the AT1 and AT2 receptors. J. Inflamm. 2004, 1, 1–12.
26. Dona, M.; Dell’Aica, L.; Calabrese, F.; Benelli, R.; Morini, M.; Albini, A.; Garbisa, S. Neutrophil restraint by green tea: Inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J. Immunol. 2003, 170, 4335–4341.
27. Shen, C.-L.; Samathanam, C.; Tatum, O.L.; Graham, S.; Tubb, C.; Cao, J.J.; Dunn, D.M.; Wang, J.-S. Green tea polyphenols avert chronic inflammation-induced myocardial fibrosis of female rats. Inflamm. Res. 2011, 60, 665–672.
28. Askenasya, N.; Kaminitza, A.; Yarkoni, S. Mechanisms of T regulatory cell function. Autoimmun. Rev. 2008, 7, 370–375.
29. Wong, C.P.; Nguyena, L.P.; Nohb, S.K.; Braya, T.B.; Brunob, R.S.; Ho, E. Induction of regulatory T cells by green tea polyphenol EGCG. Immunol. Lett. 2011, 139, 7–13.
30. Tsai, P.-Y.; Ka, S.-M.; Chang, J.-M.; Chen, H.-C.; Shui, H.-A.; Li, C.-Y.; Hua, K.-F.; Chang, W.-L.; Huang, J.-J.; Yang, S.-S., et al. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radic. Biol. Med. 2011, 51, 744–754.
31. Wu, D.; Guo, Z.; Ren, Z.; Guo, W.; Meydani, S.N. Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling. Free Radic. Biol. Med. 2009, 47, 636–643.
32. Ranjith-Kumar, C.T.; Lai, Y.; Sarisky, R.T.; Kao, C.C. Green tea catechin, epigallocatechin gallate, suppresses signaling by the dsRNA innate immune receptor RIG-I. PLoS One 2010, 5, e12878.
33. Noh, S.U.; Park, Y.M. The effect of green tea polyphenols on macrophage migration inhibitory factor-associated steroid resistance. Br. Assoc. Dermatol. 2012, 166, 653–657.
34. Ripley, B.J.M.; Fujimoto, M.; Serada, S.; Ohkawara, T.; Nishikawa, T.; Terabe, F.; Naka, T. Green tea polyphenol epigallocatechin gallate inhibits cell signaling by inducing SOCS1 gene expression. Int. Immunol. 2010, 22, 359–366.
35. Deka, A.; Vita, J.A. Tea cardiovascular disease. Pharmacol. Res. 2012, 64, 136–145.
36. Del Rio, D.; Rodriguez-Mateos, A.; Spencer, J.P.E.; Tognolini, M.; Borges, G.; Crozier, A. Dietary polyphenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal. 2012, doi:10.1089/ars.2012.4581.
37. Qin, B.; Polansky, M.M.; Harry, D.; Anderson, R.A. Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin resistant rats. Mol. Nutr. Food Res. 2010, 54, S14–S23.
38. Lorenz, M.; Urban, J.; Engelhardt, U.; Baumann, G.; Stangl, K.; Stangl, V. Green and black tea are equally potent stimuli of NO production and vasodilation: New insights into tea ingredients involved. Basic Res. Cardiol. 2009, 104, 100–110.
39. El Bedoui, J.; Oak, M.H.; Anglard, P.; Schini-Kerth, V.B. Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression. Cardiovasc. Res. 2005, 67, 317–325.
40. Bursill, C.A.; Roach, P.D. Modulation of cholesterol metabolism by the green tea polyphenol (−)-epigallocatechin gallate in cultured human liver (HepG2) cells. J. Agric. Food Chem. 2006, 54, 1621–1626.
41. Bursill, C.A.; Abbey, M.; Roach, P.D. A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 2007, 193, 86–93.
42. Alexopoulos, N.; Vlachopoulos, C.; Aznaouridis, K.; Baou, K.; Vasiliadou, C.; Pietri, P.; Xaplanteris, P.; Stefanadi, E.; Stefanadis, C. The acute effect of green tea consumption on endothelial function in healthy individuals. Eur. J. Cardiovasc. Prev. Rehabil. 2008, 15, 300–305.
43. Zheng, X.-X.; Xu, Y.-L.; Li, H.-S.; Liu, X.-X.; Hui, J.; Huang, X.-H. Green tea intake lowers fasting serum total and LDL cholesterol in adults: A meta-analysis of 14 randomized controlled trials. Am. J. Clin. Nutr. 2011, 94, 601–610.
44. Sae-Tan, S.; Grove, K.A.; Lambert, J.D. Weight control and prevention of metabolic syndrome by green tea. Pharmacol. Res. 2012, 64, 146–154.
45. Bose, M.; Lambert, J.D.; Ju, J.; Reuhl, K.R.; Shapses, S.A.; Yang, C.S. The major green tea polyphenol, (−)-Epigallocatechin-3-Gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J. Nutr. 2008, 138, 1677–1683.
46. Sae-Tan, S.; Grove, K.A.; Kennettb, M.J.; Lambert, J.D. (−)-Epigallocatechin-3-gallate increases the expression of genes related to fat oxidation in the skeletal muscle of high fat-fed mice. Food Funct. 2011, 2, 111–116.
47. Lee, M.-S.; Kim, C.-T.; Kim, I.-H.; Kim, Y. Inhibitory effects of green tea catechin on the lipid accumulation in 3T3-L1 adipocytes. Phytother. Res. 2009, 23, 1088–1091.
48. Richard, D.; Kefi, K.; Barbe, U.; Poli, A.; Bausero, P.; Visioli, F. Weight and plasma lipid control by decaffeinated green tea. Pharmocol. Res. 2009, 59, 351–354.
49. Cao, H.; Hininger-Favier, I.; Kelly, M.A.; Benaraba, R.; Dawson, H. D.; Coves, S.; Roussel, A.M.; Anderson, R.A. Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet. J. Agric. Food Chem. 2007, 55, 6372–6378.
50. Hininger-Favier, I.; Benaraba, R.; Coves, S.; Anderson, R.A.; Roussel, A.M. Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat. J. Am. Coll. Nutr. 2009, 28, 355–361.
51. Ma, J.; Li, Z.; Xing, S.; Ho, W.T.; Fu, X.; Zhao, Z.J. Tea contains potent inhibitors of tyrosine phosphatase PTP1B. Biochem. Biophys. Res. Commun. 2011, 407, 98–102.
52. Oba, S.; Nagata, C.; Nakamura, K.; Fujii, K.; Kawachi, T.; Takatsuka, N.; Shimizu, H. Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br. J. Nutr. 2010, 103, 453–459.
53. Hsu, C.-H.; Tsai, T.-H.; Kao, Y.-H.; Hwang, K.-C.; Tseng, T.-Y.; Chou, P. Effect of green tea extract on obese women: A randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. 2008, 27, 363–370.
54. Kuriyama, S.; Shimazu, T.; Ohmori, K.; Kikuchi, N.; Nakaya, N.; Nishino, Y.; Tsubono, Y.; Tsuji, I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study. J. Am. Med. Assoc. 2006, 296, 1255–1265.
55. Basu, A.; Sanchez, K.; Leyva, M.J.; Wu, M.; Betts, N.M.; Aston, C.E.; Lyons, T.J. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J. Am. Coll. Nutr. 2010, 29, 31–40.
56. Khan, N.; Mukhtar, H. Multi-targeted therapy of cancer by green tea polyphenols. Cancer Lett. 2008, 269, 269–280.
57. Ohga, N.; Hida, K.; Hida, Y.; Muraki, C.; Tsuchiya, K.; Matsuda, K.; Ohiro, Y.; Totsuka, Y.; Shindoh, M. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells. Cancer Sci. 2009, 100, 1963–1970.
58. Kato, K.; Long, N.K.; Makita, H.; Toida, M.; Yamashita, T.; Hatakeyama, D.; Hara, A.; Mori, H.; Shibata, T. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br. J. Cancer 2008, 99, 647–654.
59. Siddiqui, I.A.; Asim, M.; Hafeez, B.B.; Adhami, V.M.; Tarapore, R.S.; Mukhtar, H. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J. 2011, 25, 1198–1207.
60. Lee, Y.H.; Kwak, J.; Choi, H.K.; Choi, K.C.; Kim, S.; Lee, J.; Jun, W.; Park, H.J.; Yoon, H.G. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity. Int. J. Mol. Med. 2012, doi:10.3892/ijmm.2012.966.
61. Yuasa, Y.; Nagasaki, H.; Akiyama, Y.; Hashimoto, Y.; Takizawa, T.; Kojima, K.; Nakachi, K. DNA methylation status is inversely correlated with green tea intake and physical activity in gastric cancer patients. Int. J. Cancer 2009, 124, 2677–2682.
62. Thangapazham, R.L.; Singh, A.K.; Sharma, A.; Warren, J.; Gaddipati, J.P.; Maheshwari, R.K. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett. 2007, 245, 232–241.
63. Henning, S.M.; Wang, P.; Said, J.; Magyar, C.; Castor, B.; Doan, N.; Tosity, C.; Moro, A.; Gao, K.; Li, L., et al. Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis. J. Nutr. Biochem. 2012, 23, 1537–1542.
64. Bettuzzi, S.; Brausi, M.; Rizzi, F.; Castagnetti, G.; Peracchia, G.; Corti, A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Res. 2006, 66, 1234–1240.
65. Yang, C.S.; Wang, H.; Li, G.X.; Yang, Z.; Guan, F.; Jin, H. Cancer prevention by tea: Evidence from laboratory studies. Pharmacol. Res. 2012, 64, 113–122.
66. Yuan, J.-M.; Sun, C.; Butler, L.M. Tea and cancer prevention: Epidemiological studies. Pharmacol. Res. 2012, 64, 123–135.
67. Chow, H.-H.S.; Hakim, I.A. Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol. Res. 2012, 64, 105–112.
68. Flint, H.J.; Duncan, S.H.; Scott, K.P.; Louis, P. Interactions and competition within the microbial community of the human colon: Links between diet and health. Environ. Microbiol. 2007, 9, 1101–1111.
69. Cani, P.D.; Possemiers, S.; van de Wiele, T.; Guiot, Y.; Everard, A.; Rottier, O.; Geurts, L.; Naslain, D.; Neyrinck, A.; Lambert, D.M., et al. Changes in gut microbiota control inflammation in obese mice through mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58, 1091–1103.
70. Corr, S.C.; Li, Y.; Riedel, C.U.; O’Toole, P.W.; Hill, C.; Gahan, C.G.M. Bacteriocin production as a mechanism for the anti-infective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. USA 2007, 104, 7617–7621.
71. Lee, Y.K.; Menezes, J.S.; Umesaki, Y.; Mazmanian, S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2011, 108, 4615–4622.
72. Dunne, C.; Murphy, L.; Flynn, S.; O’Mahony, L.; O’Halloran, S.; Feeney, M.; Morrissey, D.; Thornton, G.; Fitzgerald, G.; Daly, C., et al. Probiotics: From myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie van Leeuwenhoek. 1999, 76, 279–292.
73. Crittenden, R.; Playne, M.J. Modifying the human intestinal microbiota with prebiotics. In Gastrointestinal Microbiology; Ouwehand, A.C., Vaughan, E.E., Eds.; Taylor & Francis Inc.: New York, NY, USA, 2006; pp. 285–314.
74. Khoruts, A.; Dicksved, J.; Jansson, J.K.; Sadowsky, M.J. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol. 2010, 44, 354–360.
75. Lee, H.C.; Jenner, A.M.; Low, C.S.; Lee, Y.K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res. Microbiol. 2006, 157, 876–884.
76. Su, P.; Henriksson, A.; Nilsson, C.; Mitchell, H. Synergistic effect of green tea extract and probiotics on the pathogenic bacteria, Staphylococcus aureus and Streptococcus pyogenes. World J. Microbiol. Biotechnol. 2008, 24, 1837–1841.
77. Sutherland, J.; Miles, M.; Hedderley, D.; Li, J.; Devoy, S.; Sutton, K.; Lauren, D. In vitro effects of food extracts on selected probiotic and pathogenic bacteria. Int. J. Food Sci. Nutr. 2009, 60, 717–727.
78. Molan, A.L.; Flanagan, J.; Wei, W.; Moughan, P.J. Selenium-containing green tea has higher antioxidant and prebiotic activities than regular green tea. Food Chem. 2009, 114, 829–835.
79. Green, R.J.; Murphy, A.S.; Schulz, B.; Watkins, B.A.; Ferruzzi, M.G. Common tea formulations modulate in vitro digestive recovery of green tea catechins. Mol. Nutr. Food Res. 2007, 51, 1152–1162.
80. Stalmach, A.; Troufflard, S.; Serafini, M.; Crozier, A. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol. Nutr. Food Res. 2009, 53, S44–S53.
81. Roowi, S.; Stalmach, A.; Mullen, W.; Lean, W.E.J.; Edwards, C.A.; Crozier, A. Green tea flavan-3-ols: Colonic degradation and urinary excretion of catabolites by humans. J. Agric. Food Chem. 2010, 58, 1296–1304.
82. Calani, L.; Del Rio, D.; Luisa Callegari, M.; Morelli, L.; Brighenti, F. Updated bioavailability and 48 h excretion profile of flavan-3-ols from green tea in humans. Int. J. Food Sci. Nutr. 2012, 63, 513–521.
83. Peters, C.M.; Green, R.J.; Janle, E.M.; Ferruzzi, M.G. Formulation with ascorbic acid and sucrose modulates catechin bioavailability from green tea. Food Res. Int. 2010, 43, 95–102.
84. Henning, S.M.; Niu, Y.; Lee, N.H.; Thames, G.D.; Minutti, R.R.; Wang, H.; Go, V.L.W.; Heber, D. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am. J. Clin. Nutr. 2004, 80, 1558–1564.
85. Chow, H.-H.S.; Hakim, I.A.; Vining, D.R.; Crowell, J.A.; Ranger-Moore, J.; Chew, W.M.; Celaya, C.A.; Rodney, S.R.; Hara, Y.; Alberts, D.A. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clin. Cancer Res. 2005, 11, 4627–4633.
86. Archivio, M.D.; Filesi, C.; Rosaria, V.; Scazzocchio, B.; Masella, R. Bioavailability of the polyphenols: Status and controversies. Int. J. Mol. Sci. 2010, 11, 1321–1342.
87. Sang, S.; Lambert, J.D.; Ho, C.-T.; Yang, C.S. The chemistry and biotransformation of tea constituents. Pharmacol. Res. 2011, 64, 87–99.
88. Hollman, P.C.H. Absorption, bioavailability and metabolism of flavonoids. Pharm. Biol. 2004, 42, 74–83.